Format

Send to

Choose Destination
Rev Med Inst Mex Seguro Soc. 2017 Jan-Feb;55(1):90-97.

[Mexican treatment goals for plaque psoriasis].

[Article in Spanish; Abstract available in Spanish from the publisher]

Author information

1
Servicio de Dermatología, Hospital Regional Lic. Adolfo López Mateos, ISSSTE, Ciudad de México, México. lorenaestradaaguilar@prodigy.net.mx.

Abstract

in English, Spanish

Psoriasis is a chronic inflammatory disease with a worldwide prevalence between 6 and 39% in moderate to severe forms. In European countries like Germany and England was identified that only one third of patients with moderate to severe forms will receive systemic management, this fact motivated to integrate into Europe an international consensus on treatment goals with the aim of providing support to the dermatologist by algorithms that serve as a therapeutic guide that allows you to gain control short and long term effects of this disease. The European group met to develop the definitions of severity of psoriasis, treatment goals for moderate to severe disease, and optimization options and / or therapeutic transition than a paper published in 2011 was obtained. In Mexico a working group of experts on biological therapy (GTEB), made up of 10 members and an extended group of 150 dermatologists' voters in the country for the purpose of issuing Mexico's position on the proposals of the European group was formed. In this document the findings of the Working Group of Experts on Biological Therapy in Mexico are listed.

KEYWORDS:

Biologic therapy; Psoriasis; Skin diseases

PMID:
28092253
[Indexed for MEDLINE]

Supplemental Content

Loading ...
Support Center